Back
Eagle Pharmaceuticals Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
20
EGRX
Eagle Pharmaceuticals
Last Price:
0.80
Seasonality Move:
-1.64%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
Eagle Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.52 | Sell |
| 20-day SMA: | 0.63 | Sell |
| 50-day SMA: | 2.66 | Sell |
| 200-day SMA: | 4.39 | Sell |
| 8-day EMA: | 0.56 | Sell |
| 20-day EMA: | 0.97 | Sell |
| 50-day EMA: | 2.16 | Sell |
| 200-day EMA: | 5.34 | Sell |
Eagle Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 31.92 | Sell |
| Chaikin Money Flow: | -17488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.12 - 1.88) | Sell |
| Bollinger Bands (100): | (2 - 5.58) | Sell |
Eagle Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Eagle Pharmaceuticals Stock
Is Eagle Pharmaceuticals Stock a Buy?
- Eagle Pharmaceuticals share price is 0.50 while EGRX 8-day simple moving average is 0.52, which is a Sell signal.
- The stock price of EGRX is 0.50 while Eagle Pharmaceuticals 20-day SMA is 0.63, which makes it a Sell.
- Eagle Pharmaceuticals 50-day simple moving average is 2.66 while EGRX share price is 0.50, making it a Sell technically.
- EGRX stock price is 0.50 and Eagle Pharmaceuticals 200-day simple moving average is 4.39, creating a Sell signal.
EGRX Technical Analysis vs Fundamental Analysis
Sell
20
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy or a Sell?
-
Eagle Pharmaceuticals stock is rated a Sell
The current Eagle Pharmaceuticals [EGRX] share price is $0.50. The Score for EGRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Eagle Pharmaceuticals Stock Info
Market Cap:
6.49M
Price in USD:
0.50
Share Volume:
26.23K
Eagle Pharmaceuticals 52-Week Range
52-Week High:
14.40
52-Week Low:
0.00
Sell
20
Eagle Pharmaceuticals (EGRX)
is a Sell
Eagle Pharmaceuticals Share Price Forecast
-
What is the Eagle Pharmaceuticals stock price today?
The Eagle Pharmaceuticals stock price is 0.50 USD today. -
Will EGRX stock go up or go down?
Eagle Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Eagle Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Eagle Pharmaceuticals is overvalued.
Is Eagle Pharmaceuticals Stock a Buy?
- Eagle Pharmaceuticals share price is 0.50 while EGRX 8-day exponential moving average is 0.56, which is a Sell signal.
- The stock price of EGRX is 0.50 while Eagle Pharmaceuticals 20-day EMA is 0.97, which makes it a Sell.
- Eagle Pharmaceuticals 50-day exponential moving average is 2.16 while EGRX share price is 0.50, making it a Sell technically.
- EGRX stock price is 0.50 and Eagle Pharmaceuticals 200-day simple moving average is 5.34, creating a Sell signal.
Fundamental Analysis of Eagle Pharmaceuticals
Is Eagle Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Eagle Pharmaceuticals
Should I short Eagle Pharmaceuticals stock?
- EGRX Moving Average Covergence Divergence (MACD) indicator is -0.6, suggesting Eagle Pharmaceuticals is a Sell
- Eagle Pharmaceuticals Relative Strength Index (RSI) is 31.92, which suggest Eagle Pharmaceuticals is oversold
- The Bollinger Bands (25) for Eagle Pharmaceuticals is (0.12 - 1.88), which suggest Eagle Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Eagle Pharmaceuticals is (2 - 5.58), which suggest Eagle Pharmaceuticals is a Sell
* Eagle Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.